Based on preclinical data, we designed a phase I/II clinical trial to determine the efficacy and toxicity of doxorubicin followed by paclitaxel in the treatment of advanced breast cancer (either untreated or relapsed after
Patrizia Serra, PhD
Advertisement
Articles by Patrizia Serra, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Ruxolitinib Tablets for Hematologic Malignancies
2
Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer
3
How Effective and Safe is EUS-Guided Alpha DaRT in Pancreatic Cancer?
4
SLN Surgery Omission Does Not Increase Radiotherapy Use in Breast Cancer
5